DailyDoctor Archive Specialties Get app
Back to the 24 October 2026 edition

Clinical update · 01 of 06

Lymphoedema affects about half of patients after radiotherapy for head and neck cancer

Screen for internal and external lymphoedema at every follow-up after head and neck radiotherapy and refer early.

Design
Systematic review and random-effects meta-analysis of 26 mostly retrospective studies
Population
3133 adults treated with radiotherapy for mucosal head and neck cancer
Primary outcome
Prevalence of lymphoedema
Effect
49% (95% CI 36% to 62%); grade 2 or worse 32%

A systematic review of 26 studies (3133 adults) estimated how often lymphoedema follows radiotherapy for mucosal head and neck cancer. The pooled prevalence was 49% (95% CI 36% to 62%), with internal lymphoedema — of the pharynx and larynx — in 45% and external lymphoedema of the face and neck in 37%. Where severity was graded, 32% had grade 2 or worse.

The evidence is weak: definitions and assessment varied, most studies were retrospective and single-arm, heterogeneity was very high (I² = 94%), and certainty was very low. Even so, the signal is consistent: this is a common late effect, not a rare one.

Internal lymphoedema can worsen swallowing and voice and is easily missed without endoscopy. Survivorship follow-up should look for it deliberately and refer early.

  • Ask about neck swelling, facial fullness, swallowing and voice changes at every survivorship visit after head and neck radiotherapy.
  • Look for internal lymphoedema on endoscopy, not only external swelling on examination.
  • Refer early to lymphoedema therapy where available; manual lymphatic drainage and compression are the mainstays.
  • Record a baseline neck examination before radiotherapy so later change can be judged.

Why it matters

A late effect seen in half of survivors is often unrecorded because no one looks for it.

Don't overread it

Certainty was very low and definitions varied; the true prevalence could be well above or below 49%.

The statistics, in plain English

A pooled prevalence of 49% with an interval of 36% to 62% means somewhere between a third and two-thirds of patients. An I² of 94% means studies differed greatly, largely because they defined and measured lymphoedema differently.

Read the rest in the app

You have read your two free briefings this month. The app carries all 27 specialties, every morning, free — and this finding is waiting in it.

QR code to install Daily Doctor
Get Daily Doctor — free

Scan to keep reading on your phone. No account needed to start.

headneckoncotologypaedent

Tomorrow morning, before your first patient

One edition a day for ent & head and neck surgery, written by the desk, every claim tied to its paper. Six minutes.

Get the app — free
Daily Doctor All 27 specialties, every morning. Free.
Get the app